European Commission Issues Positive Decision For Approval Of Seroquel XR As An Add-On Treatment Of Major Depressive Disorder

Posted on September 5th, 2010 by Health News

AstraZeneca announced that the European Commission (EC) has issued a positive decision for the approval of once-daily SEROQUEL XR (quetiapine fumarate) Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy…

No Comments »
Filed under: Pharmacy News

Merck’s Cladribine Tablets For Multiple Sclerosis Approved In Australia

Posted on September 5th, 2010 by Health News

Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®…

No Comments »
Filed under: Pharmacy News